418 related articles for article (PubMed ID: 18472700)
21. Role of axillary sampling in the era of sentinel lymph node biopsy: a critical review.
Bassi KK; Seenu V; Srivastava A; Al Sharara N
Indian J Cancer; 2012; 49(1):66-73. PubMed ID: 22842171
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node biopsy can replace four-node-sampling in staging early breast cancer.
Agarwal T; Kakkos SK; Cunningham DA; Darzi A; Lee D; Rajan P; Hadjiminas DJ
Eur J Surg Oncol; 2005 Mar; 31(2):122-7. PubMed ID: 15698726
[TBL] [Abstract][Full Text] [Related]
23. The value of level III clearance in patients with axillary and sentinel node positive breast cancer.
Dillon MF; Advani V; Masterson C; O'Loughlin C; Quinn CM; O'Higgins N; Evoy D; McDermott EW
Ann Surg; 2009 May; 249(5):834-9. PubMed ID: 19387317
[TBL] [Abstract][Full Text] [Related]
24. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA.
Ross MI
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):77S-81S. PubMed ID: 11599908
[TBL] [Abstract][Full Text] [Related]
25. Surgical management of the axilla: do intramammary nodes matter?
Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
[TBL] [Abstract][Full Text] [Related]
26. Selective axillary node sampling and radiotherapy to the axilla in the management of breast cancer.
Tanguay JS; Ford DR; Sadler G; Buckley L; Uppal H; Cross J; Holmes N; Fortes Mayer K; Fernando I
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):677-82. PubMed ID: 18722758
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
28. Breast sentinel lymph node dissection before preoperative chemotherapy.
Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
[TBL] [Abstract][Full Text] [Related]
29. Axillary sentinel lymph node biopsy: an overview.
Rovera F; Frattini F; Marelli M; Corben AD; Dionigi G; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S109-12. PubMed ID: 19131285
[TBL] [Abstract][Full Text] [Related]
30. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
31. The sentinel node debate in breast cancer.
Mittra I
Natl Med J India; 2008; 21(1):1-2. PubMed ID: 18472695
[No Abstract] [Full Text] [Related]
32. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer.
Ferrari A; Rovera F; Dionigi P; Limonta G; Marelli M; Besana Ciani I; Bianchi V; Vanoli C; Dionigi R
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1503-15. PubMed ID: 17069533
[TBL] [Abstract][Full Text] [Related]
34. [Feasibility of the sentinel node biopsy in breast cancer in case of histological multifocality diagnosis].
Bézu C; Coutant C; Antoine M; Moutafoff C; Guillo E; Daraï E; Rouzier R; Uzan S
Gynecol Obstet Fertil; 2009; 37(7-8):604-10. PubMed ID: 19577499
[TBL] [Abstract][Full Text] [Related]
35. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
36. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
37. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
Fleissig A; Fallowfield LJ; Langridge CI; Johnson L; Newcombe RG; Dixon JM; Kissin M; Mansel RE
Breast Cancer Res Treat; 2006 Feb; 95(3):279-93. PubMed ID: 16163445
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
39. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
[TBL] [Abstract][Full Text] [Related]
40. [Early breast cancer without axillary lymph node involvement].
Ghorbel I; Kanoun S; Kallel A; Belaid A; Azoury F; Heymann S; Pichenot C; Verstraet R; Marsiglia H; Bourgier C
Cancer Radiother; 2010 Nov; 14 Suppl 1():S127-35. PubMed ID: 21129655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
